You're viewing a free preview.You're viewing a free preview — a sample of each dataset.
People & Movers
Who is joining, leaving and founding across longevity science and aging research.
149 people moves tracked
| Person | New role | Company |
|---|---|---|
| Ivana Rubino, Ph.D. | Chief Commercial Officer | ProMIS Neurosciences |
| Karl Kieburtz, M.D., M.P.H. | Chief Medical Officer | Cerevance |
| Cara Cassino | Interim President and Chief Executive Officer | Oligomerix |
| Robert Mohr, M.D. | Chief Medical Officer | Temple |
| Avi Roy, Ph.D. | Head of Science | Temple |
| Norman John Campbell | — | — |
| Nirav Jhaveri, CFA | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Longeveron Inc. |
| Dr. Prasun Mishra | Chief Executive Officer | Longevica Therapeutics, Inc. |
| Claus Sundgreen | Chief Medical Officer | NRG Therapeutics |
| Jeffrey Emmick, MD, PhD | Advisory Board Member | Junevity |
Showing 10 of 149 people moves
7-day free trial · already have an account?
Peek at other modules
News Feed
Daily longevity science headlines — aging research, deals, trials, and policy — with AI summaries.
Companies
The longevity science company universe by segment, stage, geography and capital raised.
Funding Tracker
Every disclosed longevity science round — size, stage and the investors behind it.
Clinical Trials
Longevity science and aging research trials by phase, sponsor, status and indication.
Research
Peer-reviewed aging research distilled into investor-relevant takeaways.
Regulatory
FDA, EMA and policy developments that move aging research and the longevity market.